Latest News and Press Releases
Want to stay updated on the latest news?
-
Vital Step offers doctor-prescribed compounded semaglutide and tirzepatide GLP-1 programs online. 2026 overview covers pricing, process, and what to verify
-
Found Health's GLP-1 program, insurance check, Wegovy, Zepbound, Ozempic access, compounded options, and 2026 pricing structure — evaluated.
-
MEDVi tirzepatide GLP-1 pricing, compounded medication access, telehealth structure, and 2026 regulatory context based on publicly available info
-
2026 report evaluates MEDVi's GLP-1 weight loss claims, compounded semaglutide pricing, telehealth structure, and FDA regulatory context.
-
Consumer research report examines TrimRx telehealth GLP-1 programs, compounded semaglutide and tirzepatide pricing, access and safety in 2026
-
Wegovy Pill vs Wegovy Shot: Daily oral vs weekly injectable semaglutide differences following 2026 FDA approval. Ro.co access pathway examined.
-
Direct Meds reviews best GLP-1 weight loss shot prescription pathways for 2026 as oral semaglutide and injectable formats expand patient access.
-
MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs
Analysis examines MEDVi's compounded GLP-1 semaglutide telehealth model, FDA compounding framework, and prescription weight loss trends for 2026.
-
SynergyRx outlines how its telehealth platform connects patients with licensed providers for GLP-1 evaluation, pricing context, and pathways.
-
FDA approves oral Wegovy pill Dec 2025. Analysis compares FDA-approved injectable, oral, and compounded semaglutide access pathways for 2026.